Supporting new researchers in pancreatic cancer
Official title: Career Enhancement Program
Funded at Washington University · NIH-10916371 · Data updated 2026-11-12
This program is all about helping new researchers who want to make a difference in understanding and treating pancreatic cancer, especially by bringing in diverse voices like women and minorities, so they can work on important projects that look into the causes, prevention, and treatment of this disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | August 28, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $182,195 |
| NIH project number | 5P50CA272213-02 |
| Project ID | NIH-10916371 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are junior faculty members or early-career researchers interested in pancreatic cancer.
✕Less likely to help
Patients who are not involved in research or who are not early-career researchers in the field of pancreatic cancer may not benefit from this program.
What this research studies
This program focuses on recruiting and training new independent investigators who are dedicated to advancing translational research in pancreatic cancer. It provides financial support, educational training, and mentorship to help these researchers develop their careers. The initiative emphasizes diversity by actively recruiting women, minorities, and disabled faculty to ensure a broad range of perspectives in pancreatic cancer research. Participants will engage in projects that explore various aspects of pancreatic cancer, including its causes, prevention, and treatment.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in the understanding and treatment of pancreatic cancer.
How similar studies have gone: Similar initiatives have shown success in fostering new talent and advancing research in cancer fields, indicating a promising approach.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Gillanders, William E. — Washington University
- Study coordinator: Gillanders, William E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.